Clinical trial readout dates for Pharvaris N.V., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is June 2027.
Next readoutJune 2027in ~7 months
Upcoming readouts33 Phase 3
Market cap$2.4B
Upcoming readouts
Phase 3Deucrictibant
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) · NCT07266805
June 2027
Recruiting
Phase 2/3deucrictibant
Hereditary Angioedema; Hereditary Angioedema Type I · NCT05396105